Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Amir Hashemi-meshkini"'
Autor:
Tahmineh Reshadat-Hajiabad, Alireza Khajavi, Ali Mohammad Hosseinpour, Amin Bojdy, Amir Hashemi-Meshkini, Mehdi Varmaghani
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Since the start of the AIDS outbreak, the human immunodeficiency virus (HIV) has infected about 84.2 million people, and approximately 40.1 million people have died due to AIDS-related diseases. So, this study aims to provide a co
Externí odkaz:
https://doaj.org/article/5ed67b5d48754b8c9d5b468386f6ac1e
Autor:
Amir Hashemi-meshkini, Amirmohammad Tajik, Nayyereh Ayati, Shekoufeh Nikfar, Reza Koochak, Saeed Yaghoubifard, Azam Abbasi, Mehdi Varmaghani
Publikováno v:
Journal of Tehran University Heart Center, Vol 18, Iss 2 (2023)
Background: The present study aimed to determine the cost-effectiveness of ticagrelor compared with clopidogrel in Iranian patients with acute coronary syndrome (ACS). Methods: A 1-year decision tree model combined with a 20-year Markov transition
Externí odkaz:
https://doaj.org/article/ebff7df017e44441934c36d9c9e898f4
Autor:
Amir Hashemi-Meshkini, Reza Koochak, Shekoufeh Nikfar, Ehsan Rezaei-Darzi, Saeed Yaghoubifard
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 11, Iss 1, Pp 1-7 (2022)
Objective: In this study, we assess population-level data of COVID-19 treatments in Iran compared to Ministry of Health (MOH)-published guidelines to gain a better insight into the quality of care for this disease. Methods: National sales data of eac
Externí odkaz:
https://doaj.org/article/49163f5d54cc4e84b3e5b5213e7eefbc
Autor:
Pardis Zaboli, Amir Hashemi-Meshkini, Mehdi Varmaghani, Hadi Gholami, Iman Vazirian, Hedieh-Sadat Zekri, Shahriar Eslamitabar, Abbas Kebriaeezadeh
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 5, Iss 3, Pp 155-161 (2016)
The pharmaceutical legal framework is a very important infrastructure in achieving predefined goals in pharmaceutical sector: Accessibility, quality, and rational use of medicine. This study aims to review the current pharmaceutical sector-related le
Externí odkaz:
https://doaj.org/article/bb1b7beaa30b4311a8c26f1cda01650f
Autor:
Saeed Yaghoubifard, Arash Rashidian, Abbas Kebriaeezadeh, Ali Sheidaei, Mehdi Varmaghani, Amir Hashemi-Meshkini, Hedieh-Sadat Zekri
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 5, Iss 2, Pp 106-115 (2016)
Objective: To develop a valid and reliable instrument in the Persian language for evaluating patient satisfaction with services provided in community pharmacies. Methods: We selected a valid and reliable instrument from the literature and translated
Externí odkaz:
https://doaj.org/article/98301f2c134447579a93a15f3805526c
Autor:
Mehdi Varmaghani, Amir Hashemi-Meshkini, Akbar Abdollahiasl, Elham Heidari, Hedieh-Sadat Zekri, Saeed Yaghoubifard, Farid Dorkoosh
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 2, Iss 1/2 (2017)
Pharmaceutical expenditure is a substantial part of the health-care system budget. In Iran, people are paying about half of total pharmaceutical expenditure out of their pocket. In this study, we reviewed the Iranian pharmaceuticals financing system
Externí odkaz:
https://doaj.org/article/c42ac5a6f2dd4d9cbebdddd30d45ffcf
Autor:
Amir Hashemi-Meshkini, Mehdi Varmaghani, Mehdi Yousefi, Saeed Yaghoubifard, Hedieh-Sadat Zekri, Shekoufeh Nikfar, Abbas Kebriaeezadeh
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 3, Iss 3, Pp 88-93 (2014)
Objective: Brand-generic scheme was implemented in Iran to improve the competition in the pharmaceutical market. In this study, we aim to assess if this policy had any positive effect on efficiency of Iranian pharmaceutical companies. Methods: We us
Externí odkaz:
https://doaj.org/article/da5df648d41441d6a43740194b405fff
Autor:
Amir Hashemi-Meshkini, Khosro Keshavarz, Mehdi Varmaghani, Abbas Kebriaeezadeh, Shekoufeh Nikfar
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 1, Iss 3/4 (2015)
Background: In this study we aim to assess the clinical evidence on the effectiveness of Fulvestrant compared with other alternatives to explore whether it has any advantage in the treatment outcomes of postmenopausal advanced breast cancer or not. E
Externí odkaz:
https://doaj.org/article/d39864e99b4e43c6a0f65fea0dbc0c35
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 1, Iss 1/2 (2015)
Background: Recent advances in the intravascular diseases have led to the entrance of drug-eluting balloon (DEB) technology. The DEB is a relatively new and easier way to treat vascular stenosis. In this study as part of rapid health technology asses
Externí odkaz:
https://doaj.org/article/b51777f889ae483db90b234707496f4e
Autor:
Amir Hashemi-Meshkini
Publikováno v:
Iranian Journal of Public Health, Vol 43, Iss 5 (2014)
Externí odkaz:
https://doaj.org/article/62e2f2c6adad406b962a960c9be0d2db